Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03769857 · ClinicalTrials.gov registry record · NA
NEM® + BIOCURC® Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women
A NA study, sponsored by ESM Technologies.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT03769857 is a NA study that has completed, run by ESM Technologies. The registered enrollment target is 84 participants.
The verdict
NCT03769857, a NA study, has completed, sponsored by ESM Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
This study is intended to evaluate the combined effects of the dietary supplement NEM® brand eggshell membrane and BIOCURC® brand bioavailable curcumin versus placebo in reducing exercise-induced joint pain, stiffness \& cartilage turnover in healthy men \& women. Half of the study participants will receive NEM+BIOCURC, once daily, orally while the other half of the study participants will receive placebo, once daily, orally while performing an exercise regimen every other day for two weeks.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT NEM® + BIOCURC®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2019-01-13 |
| Est. Completion | 2019-04-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03769857
The ClinicalTrials.gov registry entry for NCT03769857 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ESM Technologies, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03769857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03769857 about?
NCT03769857 is a clinical study titled "NEM® + BIOCURC® Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women". This study is intended to evaluate the combined effects of the dietary supplement NEM® brand eggshell membrane and BIOCURC® brand bioavailable curcumin versus placebo in reducing exercise-induced joint pain, stiffness \& cartilage turnover in healthy men \& women. Half of the study participants will...
What is the current status of trial NCT03769857?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2019-01-13. Estimated completion is 2019-04-15.
What interventions are being tested in trial NCT03769857?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), NEM® + BIOCURC® (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03769857?
This trial is sponsored by ESM Technologies, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.